Advertisement
Persons > All
Find below all kinds of persons.Total search results: 8918 | Ordered by Person (ascending)
1 2 3 ... 21 22 23 ... 88 89 90
Person | Position | Organisation (Group) | Country |
---|---|---|---|
Fischer, Stefan (TVM 202010– promoted to Managing Partner (Finance) before General Partner + CFO) | General Partner (venture partner) | TVM (Group) | Germany |
Fischer, Stefan (Univ Lübeck 202006 Professor at Institute for Telematics + Vice President of Transfer + Digitalisation) | Professor | University of Lübeck (Universität zu Lübeck, UzL) | Germany |
Fischer, Stephan (MAB Discovery GmbH 201209 Managing Director + Founder) | Managing Director | MAB Discovery GmbH | Germany |
Fischer, Thomas (Eucodis 200912– CEO) | Chief Executive Officer (CEO) | Biosynth (since 9/22) (Group) | Austria |
Fischer, Wolfgang (Affimed 201709– COO before Sandoz Biopharmaceuticals + Novartis) | Chief Operating Officer (COO) | Affimed (Group) | Germany |
Fischer, Wolfgang H. (Salk Institute 201107 Staff Scientist + Head Mass Spec Core Facilty) | Head Mass Spectrometry / NMR Laboratory (university / research institute) | Salk Institute for Biological Studies, The | United States (USA) |
Fischer-Colbrie, Mark (Labcyte 201109 CEO) | Chief Executive Officer (CEO) | Danaher (Group) | United States (USA) |
Fischer-Knuppertz, Wulf (CellTool 202001– CEO before Biocrates 201306–201909 + Fisher Scientific + Roche Diagnostics) | Chief Executive Officer (CEO) | CellTool GmbH | Germany |
Fischli, Walter (Altos Venture 201808 Chair + co-founder of Actelion) | Investment Manager | Altos Venture AG | Switzerland |
Fisher, Valeria (Trophic Communications 201906) | Public Relations Manager / Investor Relations Manager | Trophic Communications GmbH | Germany |
Fisher-Pollard, Miles (Genedata 202002 Public Relations) | Public Relations Manager / Investor Relations Manager | Genedata (Group) | Switzerland |
Fisherman, Jason (C4 Therapeutics 201601– CEO before Synthesis Capital + Advent International) | Chief Executive Officer (CEO) | C4 Therapeutics Inc. (C4T) (Nasdaq: CCCC) | United States (USA) |
Fishman, Mark (Novartis Institutes of BioMedical Research 200509 President) | President/Director/Head Business Group/Unit/Division | Novartis (Group) | Switzerland |
Fitzgerald, Daniel (Geneva Biotech 201711 CEO) | Chief Executive Officer (CEO) | Geneva Biotech (CH) | Switzerland |
FitzGerald, Kevin (Activiomics 201304– CEO F-Star 201104–201205 CEO LEFT 5/12 + Isogenica + CAT) | Chief Executive Officer (CEO) | Sino Biopharm (Group) | Austria |
FitzGerald, Peter (Randox Laboratories 200710 Managing Director) | Managing Director | Randox (Group) | United Kingdom (GB) |
Fitzpatrick, David (Max Planck 201212– Scientific Director + CEO of MPFI) | President/Director/Head Business Group/Unit/Division | Max Planck Society for the Advancement of Science | United States (USA) |
Flach, Jürgen (Sirion Biotech 201106 Managing Director CEO) | Chief Executive Officer (CEO) | PerkinElmer (Group) | Germany |
Flad, Thomas (PANATecs 201104 Head Technical Sales before 200512 Managing Director) | Sales Manager / Marketing Manager | Zukunftsfonds Heilbronn (Group) | Germany |
Flade, Isabell (CeMeT GmbH 201407– Managing Director) | Managing Director | CeMeT GmbH – Center for Metagenomics | Germany |
Fladrich, Mark (Grünenthal 201709– CCO before AstraZeneca) | Chief Commercial Officer (CCO) | Grünenthal (Group) | Germany |
Flamm, Robert (Burns McClellan 202103 before Ruth Group 201612) | Public Relations Manager / Investor Relations Manager | Burns McClellan Inc. | United States (USA) |
Flatman, Steve (Lonza 201101 Head Mammalian Development Services) | Research & Development Manager | Lonza (Group) | Switzerland |
Fleck, Roman (Index Ventures 2006– Principal at Geneva office before Boehringer Ingelheim) | Principal (venture capital) | Index Ventures | Switzerland |
Fleck, Stephan (Whatman 200711– before Bayer) | n. a. | General Electric (Group) | United Kingdom (GB) |
Fleckenstein, Tamara (Elementar 201701 Event + External Communications Manager) | Public Relations Manager / Investor Relations Manager | Elementar (Group) | Germany |
Fleig, Thomas (Valerius Bioharma 201805 CFO before Ernst & Young) | Chief Financial Officer (CFO) | Valerius Biopharma AG | Switzerland |
Fleiner, Mark (Spectris 202201 President of Malvern Panalytical) | President/Director/Head Business Group/Unit/Division | Spectris (Group) | United Kingdom (GB) |
Fleming, Bill (Oxitec 201704 CFO joined 2010 before Bayer + OBN 201704– Board Member) | Chief Financial Officer (CFO) | Third Security (Randal J. Kirk) (Group) | United Kingdom (GB) |
Flenker, Ulrich (German Sport University 200804) | n. a. | Deutsche Sporthochschule Köln | Germany |
Flensberg, Mikael (CLC bio 201304 Director Global Partner Relations) | Business Development Manager / Strategy Manager | Qiagen (Group) | Denmark |
Fleurant, Mylène (Novimmune 201609– Global Head of Quality before Alvotech + Novartis Pharma + Merck Serono) | Chief Financial Officer (CFO) | Novimmune S.A. | Switzerland |
Fließbach, Holger (Alopex 200507– Managing Director) | Managing Director | Alopex GmbH | Germany |
Flintholm Jørgensen, Keld (Lundbeck 201904– EVP + CBO before Roche Global Head of Strategic Partnering) | Chief Business Officer (CBO) | Lundbeck (Group) | Denmark |
Flon, Aude (Sud de France 201111 Project Manager Multi-industrial Sector) | Administrative Officer (personnel) | Sud de France Développement | France |
Flores Martinez, Claudio (Mimotype Technologies 202310 Managing Director (CEO) + Co-Founder) | Managing Director | Mimotype Technologies GmbH | Germany |
Flores, Danilo (Mimotype Technologies 202310 Managing Director + Co-Founder) | Managing Director | Mimotype Technologies GmbH | Germany |
Flores, Lalo (Century Therapeutics 201907 CEO) | Chief Executive Officer (CEO) | Century Therapeutics (US) | United States (USA) |
Flores-Candia, Juana Lucia (Scailyte 202209 VP Strategy + Business Development) | Business Development Manager / Strategy Manager | Scailyte AG | Switzerland |
Floß, Georg (Biotest 201301– promoted COO joined Biotest 2/08) | Chief Operating Officer (COO) | Grifols (Group) | Germany |
Flückiger-Mangual, Stefanie (201809 CEO + Co-Founder) | Chief Executive Officer (CEO) | Tolremo Therapeutics AG | Switzerland |
Flöß, Lukas (Inovedis 202106 Managing Director + Co-Founder) | Managing Director | Inovedis GmbH | Germany |
Focant, Jean-François (Univ Liège 201710 Prof + Director of OBiAChem) | Professor | University of Liège, Organic and Biological Analytical Chemistry Laboratory (OBiAChem) | Belgium |
Foidart, Marc (Épimède 201711 Investment Manager) | Investment Manager | Noshaq S.A. | Belgium |
Fontoura, Alexandre (SGS 201610 Business Manager at SGS Brazil) | Business Development Manager / Strategy Manager | SGS (Group) | Brazil |
Foos, Christian (Berlin Capital Fund 200504) | n. a. | Triginta Capital (Group) | Germany |
Forer, Michael (Celtic Therapeutics 201207 CEO of ADC Therapeutics until 6/15 + Partner in Celtic Therapeutics) | Chief Executive Officer (CEO) | ADC Therapeutics (Group) | Switzerland |
Formela, Jean-François (Atlas Venture 201205 Partner joined 1993 before Schering-Plough) | Partner (venture partner) | Atlas Venture (Group) | United States (USA) |
Fornaroli, Micol (Bracco 201710 Chief Strategy Officer at Bracco Imaging SpA) | Business Development Manager / Strategy Manager | Bracco (Group) | Italy |
Forrest, Rosanna (Instinctif Partners 201603) | Public Relations Manager / Investor Relations Manager | Instinctif Partners (Group) | United Kingdom (GB) |
Forsberg, Erik (Uppsala BIO 201109 Managing Director) | Managing Director | Uppsala BIO | Sweden |
Forsberg, Roald (Indivumed 202101– CBO joined 2019 formerly CLC bio 200806 Director Scientific Solutions) | Chief Business Officer (CBO) | Indivumed (Group) | Germany |
Forss, Maria (Bico Group 202311– CEO before Vitrolife + AstraZeneca) | Chief Executive Officer (CEO) | Bico (Group) | Sweden |
Forster, Eliot (F-Star 201810– CEO before Immunocore + Creabilis + Solace Pharmaceuticals + Pfizer + GSK) | Chief Executive Officer (CEO) | Sino Biopharm (Group) | United Kingdom (GB) |
Forster, Vincent (Versantis AG 201704 CEO + Co-Founder) | Chief Executive Officer (CEO) | Genfit (Group) | Switzerland |
Fortier, Caroline (LAmAB Biologics 202302 CEO) | Chief Executive Officer (CEO) | LAmAB Biologics Inc. | United States (USA) |
Foster, James C. (Charles River 200708 President + CEO) | Chief Executive Officer (CEO) | Charles River (Group) | United States (USA) |
Foster, Jason C. (Oribiotech 202001– CEO) | Chief Executive Officer (CEO) | Ori Biotech (Oribiotech) (Group) | United Kingdom (GB) |
Foster, John (Owl Biomedical Inc 201404 President) | President/Director/Head Business Group/Unit/Division | Miltenyi Biotec (Group) | United States (USA) |
Fotev, Zisi (Cenix BioScience 200502 CBO) | Chief Business Officer (CBO) | Cenix BioScience (Group) | Germany |
Fotin-Mleczek, Mariola (CureVac 201710 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | CureVac (Group) | Germany |
Foulger, Paul (EKF Diagnostics 201307– Interim Finance Director before Company Secretary) | Chief Financial Officer (CFO) | EKF Diagnostics (Group) | United Kingdom (GB) |
Foulsham, Lawrence (Siemens 202310 Business Manager for Molecular Imaging at Siemens Healthineers GB&I) | Business Development Manager / Strategy Manager | Siemens (Group) | Germany |
Fouquet, Gerhard (Univ Kiel 201201 President + Professor) | President/Director/Head Business Group/Unit/Division | University of Kiel (Christian-Albrechts-Universität, CAU) | Germany |
Fournier, Jennifer (Waters 201902 Director Product Marketing Chemistry Group) | Sales Manager / Marketing Manager | Waters (Group) | United States (USA) |
Fowler, Sanna (Lonza 201809 Head PR Lonza Pharma & Biotech) | Public Relations Manager / Investor Relations Manager | Lonza (Group) | Switzerland |
Fowles, Richard (United Kingdom (govt) 201010 Category Manager at RCUK SSC Ltd) | n. a. | United Kingdom (GB) (govt) | United Kingdom (GB) |
Foy, Shaun P. (CRISPR Therapeutics 201404 CFO + Co-Founder + ERS Genomics CEO + Co-Founder before Nomura Phase4) | Chief Financial Officer (CFO) | CRISPR Therapeutics (Group) | Switzerland |
Foy, Teri (BMS 202112 SVP Research + Early Development, Immuno-Oncology + Cell Therapy) | President/Director/Head Business Group/Unit/Division | Bristol Myers Squibb (BMS) (Group) | United States (USA) |
Frahm, Thomas (TRI Thinking Reseach Instruments 202205 Head of Sales + BusDev formerly Norgenta) | Cluster Manager | TRI Thinking Research Instruments GmbH | Germany |
Fralish, Greg (GlycoEra 202401– CBO before 2seventy Bio + Bluebird Bio + Taleda) | Chief Business Officer (CBO) | GlycoEra (Group) | Switzerland |
Francis, Richard (Novartis 201404– Divison Head of Sandoz before Biogen Idec + Sanofi + Wyeth) | President/Director/Head Business Group/Unit/Division | Novartis (Group) | Germany |
Francisco, Elodie Caroti (Hedera Dx 202209 Head of Marketing) | Sales Manager / Marketing Manager | Hedera Dx S.A. | Switzerland |
Franco, Nicholas (Actelion 201106 Chief Business Developm Officer before Axcan Pharma Paris before Novartis Pharma AG) | Business Development Manager / Strategy Manager | Novartis (Group) | Switzerland |
Francoise, Jacques (CSM Instruments –201311 General Manager) | General Manager (management) | Anton Paar (Group) | Switzerland |
Frank, Gert (Geratherm 201507 CEO) | Chief Executive Officer (CEO) | Geratherm (Group) | Germany |
Frank, Hans-Georg (AplaGen 200810 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | AplaGen GmbH | Germany |
Frank, Peter (ScanBalt 201105 General Sectretary) | Administrative Officer (personnel) | ScanBalt Network (Scanbalt MTÜ) | Estonia |
Franken, Sebastian (Univ Bonn 201101 IBMB Team Leader Mass Spectrometry) | Head Mass Spectrometry / NMR Laboratory (university / research institute) | University of Bonn (Rheinsche Friedrich-Wilhelms-Universität Bonn) | Germany |
Frankenne, Günter (november 200611– ) | n. a. | November (Group) | Germany |
Franklin, Roger (Hadean Ventures 202007 Partner) | Partner (venture partner) | Hadean Ventures AS | Norway |
Franksson, Olof (HotSwap 201102 CEO) | Chief Executive Officer (CEO) | HotSwap (Group) | Sweden |
Frantsits, Werner (Sanochemia 201208 CEO) | Chief Executive Officer (CEO) | Sanochemia (Group) | Austria |
Franz, Christoph (Roche 201403– Board Chairman before Lufthansa CEO) | Board member, non-executive | Roche (Group) | Switzerland |
Franz, Oliver (Eppendorf 200804 Executive Director Portfolio Management PCR + Automation) | Product Manager (personnel) | Eppendorf (Group) | Germany |
Franzen, Jochen (Bruker Daltonik) | Company Founder | Bruker (Group) | Germany |
Frasch, Markus (AppliChem 200904 Managing Director) | Managing Director | Illinois Tool Works (ITW) (Group) | Germany |
Fraser, Paul D. (Univ London 201403 Professor at Royal Holloway and Bedford New College) | Professor | University of London | United Kingdom (GB) |
Fratacci, Thomas (SPRIM Global Investments 202302 CFO) | n. a. | ||
Frattini, Sergio (ASG Superconductors 202301 CEO) | Chief Executive Officer (CEO) | ASG Superconductors (Group) | Italy |
Frauendorf, Holm (Univ Göttingen 200910 Head Div Zentrale Analytik) | Head Mass Spectrometry / NMR Laboratory (university / research institute) | University of Göttingen (Georg August University) | Germany |
Frearson, Julie (Charles River 201711 Corp VP Global Discovery Services) | President/Director/Head Business Group/Unit/Division | Charles River (Group) | United States (USA) |
Frech, Kornelie (Genomatix 200608 Head of Biological Databases) | n. a. | Genomatix Software (Group) | Germany |
Fréchet, Jean M. J. (KAUST 201803 Prof + SVP Research + Innovation + Economic Development) | Professor | King Abdullah University of Science and Technology (KAUST) | Saudi Arabia |
Freedman, Stephen (Gladstone Institutes 201507 VP Corporate Liaison + Ventures) | Business Development Manager / Strategy Manager | Gladstone Institutes (Group) | United States (USA) |
Freeman, David M. (Cell Signaling Technology 201301 Head of Global Marketing) | Sales Manager / Marketing Manager | Cell Signaling Technology (CST) (Group) | United States (USA) |
Freeman, Gordon (Harvard Univ 202301 at Dana-Farber Cancer Institute + Academic Founder of NextPoint Tx) | Researcher (university / research institute) | Harvard University | United States (USA) |
Fregien, Jörg (Life Science Inkubator 201103 Managing Director) | Managing Director | Life Science Inkubator GmbH (LSI) | Germany |
Frei, Patrik (Venture Valuation 201802 CEO + Founder) | Chief Executive Officer (CEO) | Venture Valuation (Group) | Switzerland |
Freier, Gottfried W. (Kaye Scholer LLP 200809 Frankfurt/M) | Attorney / Lawyer | Arnold & Porter LLP | Germany |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top